Jin Medical International Stock Number Of Shares Shorted
| ZJYL Stock | 0.95 0.11 10.38% |
JIN MEDICAL INTERNATIONAL fundamentals help investors to digest information that contributes to JIN MEDICAL's financial success or failures. It also enables traders to predict the movement of JIN Stock. The fundamental analysis module provides a way to measure JIN MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to JIN MEDICAL stock.
JIN | Number Of Shares Shorted |
JIN MEDICAL INTERNATIONAL Company Number Of Shares Shorted Analysis
JIN MEDICAL's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current JIN MEDICAL Number Of Shares Shorted | 1.09 M |
Most of JIN MEDICAL's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JIN MEDICAL INTERNATIONAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
JIN Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for JIN MEDICAL is extremely important. It helps to project a fair market value of JIN Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since JIN MEDICAL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of JIN MEDICAL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of JIN MEDICAL's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, JIN MEDICAL INTERNATIONAL has 1.09 M of outstending shares currently sold short by investors. This is 65.93% lower than that of the Health Care Equipment & Supplies sector and 60.88% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 76.84% higher than that of the company.
JIN Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JIN MEDICAL's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of JIN MEDICAL could also be used in its relative valuation, which is a method of valuing JIN MEDICAL by comparing valuation metrics of similar companies.JIN MEDICAL is currently under evaluation in number of shares shorted category among its peers.
JIN Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0403 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 149.9 M | ||||
| Shares Outstanding | 156.55 M | ||||
| Shares Owned By Insiders | 75.84 % | ||||
| Shares Owned By Institutions | 1.14 % | ||||
| Number Of Shares Shorted | 1.09 M | ||||
| Price To Book | 6.32 X | ||||
| Price To Sales | 8.25 X | ||||
| Revenue | 19.82 M | ||||
| Gross Profit | 6.36 M | ||||
| EBITDA | 3.44 M | ||||
| Net Income | 2.88 M | ||||
| Total Debt | 4.11 M | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | 3.11 M | ||||
| Short Ratio | 2.77 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Number Of Employees | 245 | ||||
| Market Capitalization | 165.94 M | ||||
| Total Asset | 32.9 M | ||||
| Retained Earnings | 16.93 M | ||||
| Working Capital | 22.19 M | ||||
| Net Asset | 32.9 M |
About JIN MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JIN MEDICAL INTERNATIONAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL INTERNATIONAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out JIN MEDICAL Piotroski F Score and JIN MEDICAL Altman Z Score analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share 0.129 | Quarterly Revenue Growth 0.03 | Return On Assets 0.0403 |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.